FDA Approves Axicabtagene Ciloleucel for Large B-cell Lymphoma
On October 18, 2017, the Food and Drug Administration (FDA) granted regular approval to axicabtagene ciloleucel (Yescarta™) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma.
Trump Cuts Obamacare Subsidies; Trump Announces Hargan as New Acting HHS Secretary; Norman Sharpless Sworn in as NCI Director
President Trump signed an executive order ending key payments to insurers selling plans in the Affordable Care Act (ACA) marketplace. The GOP has attempted to repeal and replace ACA, known as Obamacare, several times in 2017 with little success. Trump’s move is seen as the most recent attempt to dismantled Obamacare without the need for legislation. The Trump administration released a statement citing the legality of the funding as reason to withhold payments of more than $7 billion to health insurers as part of ACA’s cost-sharing reduction payments.
- Read more about Trump Cuts Obamacare Subsidies; Trump Announces Hargan as New Acting HHS Secretary; Norman Sharpless Sworn in as NCI Director
- Add new comment
Foster Great Leaders by Leading by Example
In 2017, the ONS Board is implementing the new process where the Board of Directors appoints the next president who will be responsible for the ongoing shaping and molding of our society. During our virtual meeting on August 29, this was one of the most important topics that we discussed. The Board is committed to ensuring that our next leader has the vested interest of our organization and possesses the core competencies and values necessary to continue to move our organization forward.
Women Respond Better to Esophageal Cancer Treatment
Women with locally advanced esophageal cancer that is treated with chemotherapy and radiation therapy before surgery are more likely to have a favorable response to their cancer treatment and less likely to have recurrence than men are, according to the results of a study published in Annals of Thoracic Surgery.
Use a Self-Care Mantra to Boost Compassion
Oncology nurses are generally compassionate people and dedicated to helping others live the best they can while experiencing a life-changing illness. Over time, such dedication can lead to compassion fatigue, especially when others suffer.
ONS Members Recognized for Achievements in Oncology Nursing
Through contributions in the field, oncology nurses are driving the quality of cancer care forward, improving patient outcomes and enhancing quality of life and access to care. Whether they’re changing practice through innovation, research, excellence, or leadership, ONS members are making a big difference in practices across the country—and several have recently been recognized for their achievements in oncology nursing.
National and Local Leaders All Play a Role in the ONS Enterprise
The annual ONS Leadership Weekend brings together the boards of ONS, ONS Foundation (ONSF), and the Oncology Nursing Certification Corporation (ONCC); the ONS Leadership Development Committee; the ONCC committee chairs; and leadership representatives from all of our chapters. Many national office staff join in the planning and activities too. The weekend is a valued, traditional investment in volunteer leaders at the local and national levels. In one session during this year’s meeting in July 2017, the questions that were asked indicated to me that understanding ONS and the roles and responsibilities of the various groups in the ONS enterprise could be helpful.
What the Next Phase of the National Cancer Moonshot Initiative Means for Oncology Nurses
In one bold declaration during his final State of the Union Address in 2016, President Barack Obama raised our hopes to a singular goal—ending cancer as we know it—as he announced the National Cancer Moonshot Initiative, now called the Biden Cancer Initiative. Grounded in real research with tangible results, the intent was not even that daring: it was more realistic. Eradicating cancer, now understood to be many different aspects of the same disease, in five years was unlikely, but rather the goal was to achieve in five years what previously would take a decade.
- Read more about What the Next Phase of the National Cancer Moonshot Initiative Means for Oncology Nurses
- Add new comment
Cancer Survivors Have a Higher Rate of Opioid Prescription Use
Even 10 years after diagnosis and without recurrence, cancer survivors have a higher opioid prescription rate than healthy controls, according to the results of a study published in Cancer.
Assess and Manage Cancer-Related Pain
Despite the findings that more than 90% of cancer pain can be controlled with routine interventions, many patients continue to experience pain throughout their cancer diagnosis and treatment. The average pain score for patients on inpatient oncology units is 5.87 on a 0–10 scale, and 25% of patients spend more than 50% of the time in constant or severe pain.